Evidence map›Paper›PMID 41465235›Full record

ArticleInternational journal of molecular sciences2025

Hyerim Kim, Hyun Kim, Yeonmi Lee, Changho Park, Beomki Cho, Suyoung Son, Hyeyoung Kim, Gihyeon Kim, Jaeseong Park, Hansoo Park

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hyerim KimGenome and Company, Suwon 16229, Republic of Korea.
Hyun KimDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.ORCID 0000-0001-5026-1178
Yeonmi LeeGenome and Company, Suwon 16229, Republic of Korea.ORCID 0000-0003-4993-7972
Changho ParkGenome and Company, Suwon 16229, Republic of Korea.
Beomki ChoDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
Suyoung SonGenome and Company, Suwon 16229, Republic of Korea.ORCID 0000-0001-6519-1918
Hyeyoung KimGenome and Company, Suwon 16229, Republic of Korea.
Gihyeon KimGenome and Company, Suwon 16229, Republic of Korea.ORCID 0000-0002-9118-3919
Jaeseong ParkDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
Hansoo ParkGenome and Company, Suwon 16229, Republic of Korea.

Funding

The Korea Dementia Research Project through the Korea Dementia Research Center (KDRC), funded by the Ministry of Health & Welfare and Ministry of Science and ICT HU22C0150
6 · The paper itself

Abstract

Microbiome-derived metabolites have emerged as key mediators of the gut-brain axis, influencing cognitive function and neuroprotection. This study investigated whether

Indexed as

Cognitive DysfunctionLactobacillus delbrueckiiProbioticsScopolamineAnimalsDonepezilGastrointestinal MicrobiomeHippocampusMaleMiceMice, Inbred ICRDonepezilScopolamineAlzheimer’s diseaseLactobacillusmetabolomicsmicrobiomescopolamine

Identifiers

PMID41465235
PMCPMC12732984

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.